Biopharmaceutics 4.0, Advanced Pre-Clinical Development of mRNA-Encoded Monoclonal Antibodies to Immunosuppressed Murine Models.

Ouranidis, Andreas; Choli-Papadopoulou, Theodora; Papachristou, Eleni T; Papi, Rigini; Kostomitsopoulos, Nikolaos

Ouranidis, Andreas; Choli-Papadopoulou, Theodora; Papachristou, Eleni T; Papi, Rigini; Kostomitsopoulos, Nikolaos.

Afiliação

Ouranidis A; Department of Pharmaceutical Technology, School of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Choli-Papadopoulou T; Department of Chemical Engineering, Polytechnic School, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Papachristou ET; Department of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Papi R; Department of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Kostomitsopoulos N; Department of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.

Vaccines (Basel) ; 9(8)2021 Aug 11.

Article em En | MEDLINE | ID: mdl-34452015

Palavras-chave

COVID-19; IVT mRNA; NOD/SCID/J; SARSCoV-2; Trastuzumab; biopharmaceutics 4.0; immunodeficient; mRNA encoded antibodies; mRNA-vaccines; pharmacokinetics

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Grécia País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google